Shengmian Li
- Topics
- RNA modifications and cancer (6 papers)Colorectal Cancer Treatments and Studies (5 papers)Neuroendocrine Tumor Research Advances (4 papers)
- Cited by
- Cancer ResearchHepatologyOncology
In The Last Decade
Shengmian Li
29 papers receiving 608 citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 360
- Cancer Research 196
- Oncology 156
- Epidemiology 104
- Immunology 100
Countries citing papers authored by Shengmian Li
This map shows the geographic impact of Shengmian Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengmian Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengmian Li more than expected).
Fields of papers citing papers by Shengmian Li
This network shows the impact of papers produced by Shengmian Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengmian Li. The network helps show where Shengmian Li may publish in the future.
Co-authorship network of co-authors of Shengmian Li
This figure shows the co-authorship network connecting the top 25 collaborators of Shengmian Li. A scholar is included among the top collaborators of Shengmian Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengmian Li. Shengmian Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 9 | |
| 5 | 0 | |
| 6 | 7 | |
| 7 | 130 | |
| 8 | 5 | |
| 9 | 24 | |
| 10 | 17 | |
| 11 | 116 | |
| 12 | 46 | |
| 13 | 20 | |
| 14 | 0 | |
| 15 | 37 | |
| 16 | 34 | |
| 17 | Prognostic significance of XIAP expression in pancreatic carcinoma | 1 |
| 18 | 18 | |
| 19 | Expression of Smac, Bcl-2 and Ki-67 in pancreatic carcinoma and its prognostic significance. | 1 |
| 20 | 6 |
About Shengmian Li
Shengmian Li is a scholar working on Applied Microbiology and Biotechnology, Cancer Research and Oncology, having authored 34 papers that have together received 615 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). The work is most often cited by research in Cancer Research (196 citations), Hepatology (72 citations) and Oncology (156 citations). Shengmian Li has collaborated with scholars based in China, Hong Kong and Ethiopia. Frequent co-authors include Lan Zhang, Zhanjun Guo, Jun Yu, Ruijuan Li, Weixin Liu, Xiang Zhang, Cuimin Ding, Liuyang Zhao, Hongzhi Xu and Harry Cheuk-Hay Lau. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.